Humoral hypercalcemia of malignancy is a paraneoplastic symptom that is caused by an enhanced secretion of PTH-related protein. It is not clear yet if structural variations of the PTHLH gene influence the paraneoplastic response.
1. |
Maass PG et al. (2010) A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E. |
2. |
Kir S et al. (2014) Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. |
3. |
None (2003) 10 years of mouse cancer modifier loci: human relevance. |
4. |
Hsiao LT et al. (2002) Superior vena cava syndrome and hypercalcaemia in a patient with a primary mediastinal B-cell lymphoma secreting parathyroid hormone-related protein. |
5. |
Bakre MM et al. (2002) Parathyroid hormone-related peptide is a naturally occurring, protein kinase A-dependent angiogenesis inhibitor. |
6. |
Miao D et al. (2002) Parathyroid hormone is essential for normal fetal bone formation. |
7. |
Manenti G et al. (2000) A cancer modifier role for parathyroid hormone-related protein. |
8. |
None (2000) The physiology of parathyroid hormone-related protein. |
9. |
Lanske B et al. (1999) Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. |
10. |
Philbrick WM et al. (1998) Parathyroid hormone-related protein is required for tooth eruption. |
11. |
Wysolmerski JJ et al. (1998) Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. |
12. |
Henry JG et al. (1997) Parathyroid hormone-related protein-(1-36) is biologically active when administered subcutaneously to humans. |
13. |
Vortkamp A et al. (1996) Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. |
14. |
Karaplis AC et al. (1994) Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. |
15. |
Holick MF et al. (1994) A parathyroid hormone antagonist stimulates epidermal proliferation and hair growth in mice. |
16. |
Suva LJ et al. (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. |
17. |
Broadus AE et al. (1988) Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. |
18. |
Mangin M et al. (1989) Isolation and characterization of the human parathyroid hormone-like peptide gene. |
19. |
Moseley JM et al. (1987) Parathyroid hormone-related protein purified from a human lung cancer cell line. |
20. |
Mangin M et al. (1988) Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. |
21. |
Yasuda T et al. (1989) Characterization of the human parathyroid hormone-like peptide gene. Functional and evolutionary aspects. |
22. |
Hammonds RG et al. (1989) Purification and characterization of recombinant human parathyroid hormone-related protein. |
23. |
Hendy GN et al. (1990) Gene for parathyroid hormone-like peptide is on mouse chromosome 6. |
24. |
Wysolmerski JJ et al. (2001) Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction. |
25. |
Klopocki E et al. (2010) Deletion and point mutations of PTHLH cause brachydactyly type E. |
26. |
Lanske B et al. (1996) PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. |
27. |
OMIM.ORG article Omim 168470 |